HERZKLAPPENPROTHESE

European patent · EP3490501 · In force

Register entry

Publication number
EP3490501
Application number
EP17837573
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 1, 2017
Published
Jun 5, 2019
Granted
Oct 28, 2020
Protection ends at the latest
Jul 31, 2037
Next annual fee due
Aug 31, 2027
IPC classes
A61F 2/24 (2006.01)
Priority
US 201662369678 P 01.08.2016
US 201715664430 31.07.2017
PCT application
PCT/US2017/044983 01.08.2017
PCT publication
WO2018/026865 08.02.2018
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  4. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  5. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  6. Oct 28, 2020

    Granted

    Published in Swissreg on 28.10.2020

Parties

Holder

Edwards Lifesciences Corporation

One Edwards Way, Irvine, CA 92614, US

Inventor

SENESH, Gil

Irvine CA 92614, US

CHU, Waina Michelle

Irvine CA 92614, US

SHERMAN, Elena

Irvine CA 92614, US

TSYPENYUK, Alexey M.

Irvine CA 92614, US

BARASH, Alexander

Irvine CA 92614, US

BUKIN, Michael

Irvine CA 92614, US

YOHANAN, Ziv

Irvine CA 92614, US

LEVI, Tamir S.

Irvine CA 92614, US

GUROVICH, Nikolay

Irvine CA 92614, US

KERSH, Dikla

Irvine CA 92614, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.